Evidence map›Paper›PMID 35016813›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2022

Higher levels of allograft injury in black patients early after heart transplantation.

Amar Doshi, Keyur B Shah, Sean Agbor-Enoh, Zackary Tushak, Victoria Garcia, Hyesik Kong, Moon K Jang, Steven Hsu, Erika D Feller, Maria E Rodrigo and 9 more

Abstract read
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Amar DoshiDivision of Cardiology, Virginia Commonwealth University, Richmond, Virginia.
Keyur B ShahDivision of Cardiology, Virginia Commonwealth University, Richmond, Virginia; Genomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland.
Sean Agbor-EnohGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Laborarory of Applied Precision Omics (APO), Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland; Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
Zackary TushakDivision of Cardiology, Virginia Commonwealth University, Richmond, Virginia.
Victoria GarciaDivision of Cardiology, Virginia Commonwealth University, Richmond, Virginia.
Hyesik KongGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Laborarory of Applied Precision Omics (APO), Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Moon K JangGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Laborarory of Applied Precision Omics (APO), Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Steven HsuGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
Erika D FellerGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Division of Cardiology, University of Maryland Medical Center, Baltimore, Maryland.
Maria E RodrigoGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Advanced Heart Failure Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
Samer S NajjarGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Advanced Heart Failure Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
Ilker TuncGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Bioinformatics and Computational Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Yanqin YangGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland.
Seiyon LeeDepartment of Biostatistics, George Mason University, Fairfax Virginia.
Michael A SolomonCritical Care Medicine Department, National Institutes of Health Clinical Center and Cardiovascular Branch, National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, Maryland.
Gerald BerryDepartment of Pathology, Stanford University School of Medicine, Palo Alto, California.
Charles MarboeDepartment of Pathology, New York Presbyterian University Hospital of Cornell and Columbia, New York, New York.
Palak ShahGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Heart Failure, Mechanical Circulatory Support and Transplant, Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: Palak.shah@inova.org.
Hannah A ValantineGenomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland; Laborarory of Applied Precision Omics (APO), Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland; Department of Medicine, Stanford University School of Medicine, Palo Alto, California. Electronic address: hvvk@stanford.edu.

Funding

Cell-free DNA to detect transplant rejectionZIAHL006268 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI AGBOR-ENOH, SEAN · 2021 to 2025
$8.8M
MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac TransplantationK23HL143179 · NHLBI · INOVA HEALTH CARE SERVICES · PI SHAH, PALAK · 2020 to 2024
$927k
NHLBI NIH HHS K23 HL143179
6 · The paper itself

Abstract

Black patients suffer higher rates of antibody-mediated rejection and have worse long-term graft survival after heart transplantation. Donor-derived cell free DNA (ddcfDNA) is released into the blood following allograft injury. This study analyzed %ddcfDNA in 63 heart transplant recipients categorized by Black and non-Black race, during the first 200 days after transplant. Immediately after transplant, %ddcfDNA was higher for Black patients (mean [SE]: 8.3% [1.3%] vs 3.2% [1.2%], p = 0.001). In the first week post-transplant, the rate of decay in %ddcfDNA was similar (0.7% [0.68] vs 0.7% [0.11], p = 0.78), and values declined in both groups to a comparable plateau at 7 days post-transplant (0.46% [0.03] vs 0.45% [0.04], p = 0.78). The proportion of Black patients experiencing AMR was higher than non-Black patients (21% vs 9% [hazard ratio of 2.61 [95% confidence interval: 0.651-10.43], p = 0.18). Black patients were more likely to receive a race mismatched organ than non-Black patients (69% vs 35%, p = 0.01), which may explain the higher levels of early allograft injury.

Indexed as

Graft RejectionHeart TransplantationAllograftsGraft SurvivalHumansTissue DonorsTransplantation, Homologousacute rejectionbiomarkercardiac transplantationcell-free DNAgraft injury

Identifiers

PMID35016813
PMCPMC10228542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.